2024-09-17 Conversion | 2024-09-17 6:16 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Members of 10% Group 10% Owner | 16,809,237 | $0 | 897,587 (Indirect) | View |
Ownership | 2024-09-12 9:07 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 1,725,174 (Indirect) | View |
Ownership | 2024-03-08 5:43 pm | N/A N/A | AdaptHealth Corp. | AHCO | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt IV L.P. DEERFIELD PARTNERS L.P. Deerfield Private Design Fund IV L.P. Deerfield Mgmt L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 27,654,923 (Indirect) | View |
2023-07-28 Other | 2023-08-01 5:24 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Flynn James E Director by Deputization Director 10% Owner | 1,600,000 | $0 | 2,250,000 (Indirect) | View |
Ownership | 2022-11-14 6:12 pm | N/A N/A | Frazier Lifesciences Acquisition Corp | FLAC | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner | 0 | $0 | 2,572,986 (Indirect) | View |
Ownership | 2022-11-07 6:23 pm | N/A N/A | Nuvalent Inc. | NUVL | DEERFIELD PARTNERS L.P. Director by Deputization Director 10% Owner | 0 | $0 | 650,000 (Direct) | View |
Ownership | 2022-09-20 8:30 pm | N/A N/A | Larimar Therapeutics Inc. | LRMR | DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Dir. by Deputization/10% Group Director 10% Owner | 0 | $0 | 2,777,777 (Direct) | View |
2022-06-30 Option Award | 2022-07-05 5:27 pm | 2022-06-30 2030-06-30 | Acutus Medical Inc. | AFIB | Flynn James E Deerfield Mgmt L.P. Deerfield Mgmt III L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Private Design Fund III L.P. Director by Deputization Director 10% Owner | 3,779,018 | $0 | 3,779,018 (Indirect) | View |
2022-05-10 Conversion | 2022-05-10 6:22 pm | N/A N/A | PepGen Inc. | PEPG | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. Possible Member of 10% Group 10% Owner | 815,106 | $0 | 476,813 (Indirect) | View |
Ownership | 2022-05-05 8:00 pm | N/A N/A | PepGen Inc. | PEPG | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 536,960 (Indirect) | View |
2021-11-12 Other | 2021-11-16 9:34 pm | N/A N/A | Oncology Institute Inc. | DFPH | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Possible Members of 10% Group 10% Owner | 5,150,390 | $0 | 7,972,273 (Indirect) | View |
2021-11-12 Conversion | 2021-11-16 9:34 pm | N/A N/A | Oncology Institute Inc. | DFPH | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Possible Members of 10% Group 10% Owner | 85,153 | $0 | 7,972,273 (Indirect) | View |
2021-10-26 Conversion | 2021-10-28 7:15 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Possible Member of 10% Group 10% Owner | 15,129,450 | $0 | 1,143,972 (Indirect) | View |
Ownership | 2021-10-21 9:36 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 1,512,944 (Indirect) | View |
2021-07-30 Option Award | 2021-08-03 8:27 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Flynn James E Director by Deputization Director 10% Owner | 650,000 | $10 | 2,250,000 (Indirect) | View |
Ownership | 2021-07-27 9:50 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Flynn James E Director by deputization Director 10% Owner | 0 | $0 | 5,166,250 (Indirect) | View |
2021-06-08 Option Award | 2021-06-10 5:48 pm | N/A N/A | Deerfield Healthcare Technology Acquisitions Corp. | CMAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Director by Deputization Director 10% Owner | 10,000,000 | $10 | 3,638,667 (Indirect) | View |
2021-06-08 Option Award | 2021-06-10 5:48 pm | 2021-07-21 2026-06-08 | Deerfield Healthcare Technology Acquisitions Corp. | CMAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Director by Deputization Director 10% Owner | 2,916,667 | $0 | 3,638,667 (Indirect) | View |
2021-06-08 Other | 2021-06-10 5:48 pm | 2021-07-21 2026-06-08 | Deerfield Healthcare Technology Acquisitions Corp. | CMAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Director by Deputization Director 10% Owner | 672,000 | $0 | 3,638,667 (Indirect) | View |
2021-06-08 Exercise | 2021-06-10 5:48 pm | N/A N/A | Deerfield Healthcare Technology Acquisitions Corp. | CMAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Director by Deputization Director 10% Owner | 3,418,750 | $0 | 3,638,667 (Indirect) | View |
2021-06-01 Conversion | 2021-06-03 5:04 pm | N/A N/A | Singular Genomics Systems Inc. | OMIC | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. *Possible Member of 10% Group 10% Owner | 26,457,723 | $0 | 1,657,148 (Indirect) | View |
2021-06-01 Conversion | 2021-06-03 5:04 pm | N/A N/A | Singular Genomics Systems Inc. | OMIC | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. *Possible Member of 10% Group 10% Owner | 577,148 | $17.6 | 1,657,148 (Indirect) | View |
Ownership | 2021-05-26 9:24 pm | N/A N/A | Singular Genomics Systems Inc. | OMIC | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 7,642,019 (Indirect) | View |
2021-05-04 Conversion | 2021-05-04 12:34 pm | N/A N/A | Werewolf Therapeutics Inc. | HOWL | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner | 16,947,881 | $0 | 2,552,787 (Indirect) | View |
Ownership | 2021-04-29 5:42 pm | N/A N/A | Werewolf Therapeutics Inc. | HOWL | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner | 0 | $0 | 1,752,787 (Indirect) | View |
2021-02-09 Conversion | 2021-02-09 2:55 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Member of 10% Group 10% Owner | 1,717,033 | $0 | 2,382,033 (Indirect) | View |